fluocinolone acetonide has been researched along with Branch Vein Occlusion in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandello, F; Borrelli, E; Corbelli, E; Giuffrè, C; Querques, G; Sacconi, R | 1 |
| Comyn, O; Hykin, PG; Lightman, SL | 1 |
| Fekrat, S; Jaffe, GJ; Ramchandran, RS; Stinnett, SS | 1 |
| Fujii, S; Kuno, N | 1 |
| Fung, AE; Hung, D; Lim, JI; Wieland, M; Wong, V | 1 |
| Joussen, AM; Pleyer, U; Ruokonen, P; van der Velden, KH; Winterhalter, S | 1 |
| Jaffe, GJ; Jain, N; Stinnett, SS | 1 |
| Nentwich, MM; Ulbig, MW | 1 |
| Holekamp, NM; Pearson, A; Thomas, MA | 1 |
| Lightman, S; McCluskey, P; Sivaprasad, S | 1 |
6 review(s) available for fluocinolone acetonide and Branch Vein Occlusion
| Article | Year |
|---|---|
Emerging therapies in the management of macular edema: a review.
Topics: Antibodies, Monoclonal, Humanized; Clinical Trials as Topic; Dexamethasone; Diabetic Retinopathy; Fluocinolone Acetonide; Humans; Macular Edema; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Vein Occlusion; Uveitis | 2019 |
Corticosteroid intravitreal implants vs. ranibizumab for the treatment of vitreoretinal disease.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Macular Edema; Ranibizumab; Retinal Vein Occlusion; Treatment Outcome; Uveitis; Visual Acuity | 2013 |
Biodegradable intraocular therapies for retinal disorders: progress to date.
Topics: Absorbable Implants; Angiogenesis Inhibitors; Clinical Trials as Topic; Dexamethasone; Diabetic Retinopathy; Drug Administration Routes; Drug Delivery Systems; Epithelial Cells; Fluocinolone Acetonide; Humans; Intraocular Pressure; Macular Degeneration; Macular Edema; Retinal Diseases; Retinal Vein Occlusion; Uveitis; Vitreous Body | 2010 |
[Intravitreal implants: drug carriers and carriers of hope?].
Topics: Adrenal Cortex Hormones; Chronic Disease; Dexamethasone; Diabetic Retinopathy; Drug Carriers; Drug Implants; Drug Resistance; Fluocinolone Acetonide; Humans; Immunosuppressive Agents; Macular Edema; Randomized Controlled Trials as Topic; Retinal Vein Occlusion; Secondary Prevention; Uveitis, Intermediate; Uveitis, Posterior; Visual Acuity; Vitreous Body | 2011 |
The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacy.
Topics: Adrenal Cortex Hormones; Biological Availability; Delayed-Action Preparations; Dexamethasone; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Humans; Intravitreal Injections; Macular Degeneration; Macular Edema; Posterior Eye Segment; Retinal Vein Occlusion; Triamcinolone Acetonide; Uveitis, Posterior | 2012 |
Intravitreal steroids in the management of macular oedema.
Topics: Dexamethasone; Fluocinolone Acetonide; Glucocorticoids; Humans; Inflammation; Injections; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2006 |
2 trial(s) available for fluocinolone acetonide and Branch Vein Occlusion
| Article | Year |
|---|---|
Sustained-release intravitreal liquid drug delivery using triamcinolone acetonide for cystoid macular edema in retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Cohort Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluocinolone Acetonide; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2011 |
The safety profile of long-term, high-dose intraocular corticosteroid delivery.
Topics: Adult; Angioid Streaks; Cataract; Choroid Diseases; Choroidal Neovascularization; Drug Delivery Systems; Drug Implants; Feasibility Studies; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Histoplasmosis; Humans; Intraocular Pressure; Male; Middle Aged; Myopia, Degenerative; Ocular Hypertension; Prospective Studies; Retinal Vein Occlusion; Safety; Treatment Outcome; Visual Acuity | 2005 |
2 other study(ies) available for fluocinolone acetonide and Branch Vein Occlusion
| Article | Year |
|---|---|
Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results.
Topics: Chronic Disease; Drug Delivery Systems; Drug Implants; Female; Fluocinolone Acetonide; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Pilot Projects; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Vitreous Body | 2008 |
Prospective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month results.
Topics: Aged; Cataract Extraction; Chronic Disease; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Trabeculectomy; Visual Acuity; Vitreous Body | 2012 |